Cite
HARVARD Citation
Longstaff, C. et al. (2019). Increased urokinase and consumption of α2‐antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay. Journal of thrombosis and haemostasis. pp. 195-205. [Online].